Salbutamol pharmacology
Pro Research Analysisby 
Searched over 200M research papers for "salbutamol pharmacology"
Salbutamol Pharmacology: Mechanism of Action and Selectivity
Salbutamol is a selective beta-2 adrenergic receptor agonist, meaning it primarily stimulates beta-2 receptors found in the bronchial smooth muscle, leading to bronchodilation. This selectivity results in effective relief of bronchospasm with minimal cardiac stimulation compared to non-selective agents like isoprenaline, making it a preferred treatment for asthma and other reversible obstructive airway diseases 48. Its pharmacological effects are reduced or blocked by beta-receptor antagonists .
Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion
Absorption and Bioavailability
Salbutamol can be administered via inhalation, orally, or intravenously, with each route showing distinct pharmacokinetic profiles. Inhaled salbutamol is rapidly absorbed, with bronchodilation occurring within minutes, while oral administration leads to peak plasma levels in 1–3 hours and a slightly delayed onset of action 135. The majority of an inhaled dose is swallowed, but the therapeutic effect is due to local deposition in the lungs .
Distribution and Enantioselectivity
Salbutamol is a racemic mixture, but only the (R)-enantiomer is pharmacologically active. The (R)-enantiomer is metabolized and cleared faster than the (S)-enantiomer, resulting in lower bioavailability of the active form after oral administration 610. Weight and body surface area significantly affect the drug’s distribution and clearance, especially in children 910.
Metabolism and Excretion
Salbutamol undergoes extensive pre-systemic metabolism, primarily through sulfation in the liver, lung, and duodenum, with significant variability among individuals 67. Both unchanged drug and metabolites are excreted in the urine, with 65–97% of the dose recoverable depending on the route of administration 16.
Pharmacodynamics: Onset, Duration, and Efficacy
Salbutamol has a rapid onset of action, typically less than 15 minutes for inhaled and less than 30 minutes for oral administration 35. Its bronchodilatory effect is robust, with inhaled salbutamol providing greater and faster relief than oral forms, despite lower systemic concentrations 25. The duration of action is longer than that of isoprenaline, and inhaled salbutamol is about 10 times more potent than isoprenaline in animal models .
Clinical Use and Dosing Considerations
Inhaled salbutamol is the first-line therapy for acute bronchospasm due to its rapid and effective bronchodilation and lower risk of systemic side effects 57. Oral and intravenous formulations are reserved for patients unable to use inhalers or in severe, life-threatening situations 510. Dosing must be individualized, especially in children, as age, weight, and health status influence pharmacokinetics and risk of toxicity 7910.
Safety and Adverse Effects
Salbutamol is generally well tolerated, but side effects such as tremor, tachycardia, and hypokalemia are dose-related and more common with oral and intravenous administration . The (S)-enantiomer may contribute to adverse reactions, highlighting the importance of dosing strategies that minimize its accumulation, particularly in children 610.
Conclusion
Salbutamol is a highly effective, selective beta-2 agonist with rapid onset and strong bronchodilatory effects, especially when inhaled. Its pharmacokinetics and pharmacodynamics vary with route of administration, patient age, and individual characteristics. Careful consideration of these factors ensures optimal efficacy and safety in the management of asthma and other obstructive airway diseases 12345678+2 MORE.
Sources and full results
Most relevant research papers on this topic